The latest omicron subvariants—especially the currently dominant BA.4 and BA.5 forms—are even better at eluding vaccines and most treatments, find researchers at Columbia University.
Community outreach and restricting online scheduling to certain zip codes helped increase vaccine uptake among Black and Hispanic residents, new study says.
Columbia scientists have joined a regional consortium to accelerate the development of new drugs that target SARS-CoV-2, other coronaviruses, and viruses that could lead to future pandemics.
Columbia/NYSPI researchers are examining how millions of college students are addressing COVID-19 challenges, including academic/life plans, decision-making, substance use, and mental well-being.
For mental health professionals, teletherapy can feel like it’s “one step removed,” although studies suggest it produces outcomes statistically equivalent to face-to-face treatment.
New data from Columbia and other ECMO centers throughout the world show that more than 60% of severe COVID-19 patients who receive ECMO, a heart-lung life support machine, survive.
Outbreaks of SARS-CoV-2 may become a regular occurrence depending on the risk of reinfection, vaccine availability and efficacy, and interactions with other viruses, Mailman researchers say.
Moms with COVID-19 who take basic precautions rarely pass the virus to their newborns, even if breastfeeding and rooming together, finds a new study at Columbia University and NewYork-Presbyterian.
Video lectures and virtual labs from the Mailman School of Public Health's two-day "COVID-19 From Virus to Vaccine" course in late August are now online and available to all.
Months after recovering from a mild case of COVID-19, even healthy young adults are experiencing memory problems, fatigue, mood changes, and other neurological and psychiatric issues.